Tilray Brands Future Growth

Future criteria checks 1/6

Tilray Brands is forecast to grow earnings and revenue by 77.6% and 10.1% per annum respectively. EPS is expected to grow by 86.5% per annum. Return on equity is forecast to be -0.4% in 3 years.

Key information

77.6%

Earnings growth rate

86.5%

EPS growth rate

Pharmaceuticals earnings growth	23.9%
Revenue growth rate	10.1%
Future return on equity	-0.4%
Analyst coverage	Good
Last updated	30 Jul 2024

Recent future growth updates

Recent updates

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jul 31

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

May 01

Tilray Could Break Down

Apr 07

Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Mar 27

Tilray: Big Opportunities Ahead In Germany And Alcohol Segment

Mar 12

Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Jan 25

Tilray Remains Stuck In Neutral

Jan 10

Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking

Dec 19

Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%

Oct 10

Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results

Oct 06

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate

Sep 18

Little Excitement Around Tilray Brands, Inc.'s (NASDAQ:TLRY) Revenues

Apr 17

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 28% Undervalued

Feb 03

Earnings and Revenue Growth Forecasts

NasdaqGS:TLRY - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
5/31/2027	1,081	-4	81	107	4
5/31/2026	945	-60	66	80	8
5/31/2025	898	-58	19	20	8
5/31/2024	789	-222	-60	-31	N/A
2/29/2024	743	-352	-50	-18	N/A
11/30/2023	700	-1,430	-45	-21	N/A
8/31/2023	651	-1,443	16	38	N/A
5/31/2023	627	-1,453	-13	8	N/A
2/28/2023	596	-1,792	-70	-56	N/A
11/30/2022	603	-578	-102	-84	N/A
8/31/2022	614	-501	-151	-130	N/A
5/31/2022	628	-477	-211	-177	N/A
2/28/2022	617	42	-182	-148	N/A
11/30/2021	589	-275	-134	-101	N/A
8/31/2021	564	-375	-123	-82	N/A
5/31/2021	513	-367	-84	-45	N/A
2/28/2021	468	-521	-109	-58	N/A
11/30/2020	462	-243	-182	-105	N/A
8/31/2020	426	-149	-221	-138	N/A
5/31/2020	405	-103	-199	-101	N/A
2/29/2020	387	22	-215	-104	N/A
11/30/2019	338	-63	-198	-78	N/A
8/31/2019	263	-16	-190	-49	N/A
5/31/2019	179	-25	-198	-42	N/A
2/28/2019	92	-28	-194	-33	N/A
11/30/2018	43	63	-211	-17	N/A
8/31/2018	34	27	-195	-12	N/A
5/31/2018	28	23	-162	-4	N/A
2/28/2018	24	25	N/A	1	N/A
11/30/2017	20	18	N/A	3	N/A
8/31/2017	18	15	N/A	0	N/A
5/31/2017	15	3	N/A	4	N/A
2/28/2017	13	6	N/A	4	N/A
11/30/2016	11	2	N/A	2	N/A
8/31/2016	9	1	N/A	1	N/A
5/31/2016	6	0	N/A	-1	N/A
2/29/2016	5	-1	N/A	-2	N/A
11/30/2015	3	-3	N/A	-3	N/A
8/31/2015	1	-4	N/A	-3	N/A
5/31/2015	0	-5	N/A	-4	N/A
2/28/2015	0	-5	N/A	-4	N/A
11/30/2014	N/A	-3	N/A	-2	N/A
8/31/2014	N/A	-3	N/A	-2	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TLRY is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TLRY is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TLRY is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TLRY's revenue (10.1% per year) is forecast to grow faster than the US market (8.5% per year).

High Growth Revenue: TLRY's revenue (10.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: TLRY is forecast to be unprofitable in 3 years.

Tilray Brands Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Forecast to breakeven in 2027

Consensus EPS estimates fall by 31%

Price target decreased by 8.0% to US$2.37

No longer forecast to breakeven

No longer forecast to breakeven

Recent updates

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 47% Below Their Intrinsic Value Estimate

New minor risk - Profitability

Full year 2024 earnings: EPS misses analyst expectations

Tilray Shows Some Nice Improvement In Q4

Tilray Brands, Inc. to Report Q4, 2024 Results on Jul 29, 2024

Tilray Should Be Cut From Your Portfolio

Get Ready to Elevate Your Cannabis Experience with Good Supply's Latest Signature Vape Innovations

Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic Brews

Tilray Brands, Inc. Announces the Launch of 'Purple Churro,' by Redecan Cannabis

President exercised options to buy US$1.5m worth of stock.

Insufficient new directors

Tilray Brands, Inc. Announces Good Supply Launches 'Twisted' All-In-One Vape

Forecast to breakeven in 2027

Why Bears Think Tilray Brands Will Continue To Dip

Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’

Tilray Takes A Step Forward

Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $250 million.

Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $250 million.

Tilray Brands, Inc Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage

Tilray Brands, Inc.'s Subsidiary Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

Tilray Brands, Inc. Introduces New Signature 'Bud Squad' Products

Consensus EPS estimates fall by 31%

Price target decreased by 8.0% to US$2.37

No longer forecast to breakeven

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Tilray Could Break Down

Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis Use

Tilray Brands, Inc. to Report Q3, 2024 Results on Apr 09, 2024

Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Tilray Brands, Inc. Announces Redecan Cannabis Launches New Spring Lineup

Tilray Brands, Inc. Introduces New Naturally Flavoured CBG Infused Cannabis Beverages

Tilray: Big Opportunities Ahead In Germany And Alcohol Segment

Manitoba Harvest Hemp Foods Introduces Protein-Rich Breakfast Staples with New Superseed Instant Oatmeal

Tilray Brands, Inc. Announces the Latest Craft Flower Releases by Premium Cannabis Brand, Broken Coast

Tilray Brands, Inc. Debuts Two New Ready-To-Drink Cold Brew Tea Beverages by Its Premium Cannabis Wellness Brand, Solei

No longer forecast to breakeven

New minor risk - Share price stability

Tilray Brands, Inc. Shares its Cannabis Lineup for Sports Fans

Forecast to breakeven in 2026

Tilray Brands Unveils Craft Beer Locks for the Big Game

Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Tilray Brands, Inc. Unveils the Latest Additions to the Diamond Collection from Premium Cannabis Brand, RIFF

Consensus EPS estimates upgraded to US$0.23 loss

Consensus EPS estimates upgraded to US$0.23 loss

No longer forecast to breakeven

Tilray Remains Stuck In Neutral

Second quarter 2024 earnings released: US$0.07 loss per share (vs US$0.11 loss in 2Q 2023)

Tilray Brands, Inc. to Report Q2, 2024 Results on Jan 09, 2024

Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking

Tilray Brands, Inc. Through Its Wholly-Owned Licensed Subsidiaries, Aphria Inc, and Hexo Operations Inc., and Truss Beverages Company Limited Unveil Canadian Cannabis Lineup for the Holidays

Tilray Brands, Inc. Announces the Launch of Redecan’S New Redees ‘Hemp’d’ Pre-Rolls

Tilray Brands, Inc. Expands Cannabis Beverage Portfolio with New THC, CBG and CBD Drink Innovations by Top-Performing Canadian Brands

Good Supply Cannabis Launches 'Get Blitzen’d' Holiday Campaign and New Limited-Edition Products Across Canada

Consensus revenue estimates increase by 14%

Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%

Tilray Brands, Inc. (NasdaqGS:TLRY) acquired 1000652011 Ontario Inc. from MediPharm Labs Corp. (TSX:LABS) for CAD 8.5 million.

Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results

No longer forecast to breakeven

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Tilray Brands, Inc., Annual General Meeting, Nov 21, 2023

New minor risk - Shareholder dilution

Tilray Brands, Inc. to Report Q1, 2024 Results on Oct 04, 2023

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate

Consensus EPS estimates fall by 35%

Now 21% undervalued

Tilray Brands, Inc. Debuts Two New Ready-To-Drink Carbonated Beverages by Its Premium Cannabis Wellness Brand, Solei

Tilray Brands, Inc. (NasdaqGS:TLRY) acquired remaining 57.5% stake in Truss Beverage Co.™ from Molson Coors Canada Inc. (TSX:TPX.B).

Tilray Brands, Inc. Announces the Launch of the New Juiced Infused Pre-Rolls by Its Canadian Cannabis Brand, Good Supply

New major risk - Share price stability